PhilHealth and PPPI collaborate to ensure access to free medicines under Konsulta

The Philippine Pharma Procurement Inc. (PPPI) led by its President and CEO Undersecretary Maria Blanca Kim B. Lokin met with the top management of the Philippine Health Insurance Corporation (PhilHealth) headed by President and CEO Emmanuel R. Ledesma, Jr. last 14 August 2024 at the PhilHealth head office.

The meeting discussed initiatives that both corporations will collaborate on to ensure availability of medicines for the benefit programs of PhilHealth, specifically for the Konsulta and GAMOT programs. Konsulta or the Konsultasyong Sulit Tama program is a comprehensive outpatient primary care benefit package that provides capitation payments for free annual check-ups, health risk screening, selected diagnostic tests and medicines while GAMOT or the Guaranteed and Accessible Medications for Outpatient Treatment is a standalone out-patient program which covers select essential medicines.

PPPI will be rolling out an improved Botika Ng Bayan to serve as the access points for medicines that are given free under the above-mentioned programs of PhilHealth. This initiative will ensure that patients who are diagnosed under the Konsulta program are assured access to the medicines they need to treat and manage their condition.

An attached agency of the DTI, the PPPI is a subsidiary of the Philippine International Trading Corporation (PITC) and an affiliate of the National Development Company (NDC). It is mandated to procure and distribute medicines and medical supplies to both government and private hospitals and other health facilities nationwide. PPPI’s mission is to ensure that all Filipinos have access to safe, efficacious, and affordable medicines.